Prothena | PRTA - Дебиторская задолженность





Дебиторская задолженность Изменить Дата
Acadia Pharmaceuticals USD 166.33M 17.95M 2026-06
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Akebia Therapeutics USD 47.03M 19.19M 2025-12
ALKERMES USD 456.48M 48.85M 2026-06
Alnylam Pharmaceuticals USD 912.74M 28.78M 2026-06
Amgen USD 10.23B 1.09B 2026-06
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 1.06B 157.13M 2026-06
Exelixis USD 322.21M 6.73M 2026-06
Immunic USD 333K 156K 2025-12
Incyte USD 1.13B 73.7M 2026-06
Ionis Pharmaceuticals USD 58.84M 15.16M 2026-06
MacroGenics USD 10.42M 2.95M 2026-03
Nektar Therapeutics USD 3.6M 1.82M 2026-03
Neurocrine Biosciences USD 887M 118.9M 2026-06
Prothena USD 5.16M 0 2023-12
Regeneron Pharmaceuticals USD 6.57B 834.4M 2026-06
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
Vertex Pharmaceuticals USD 2.13B 138.2M 2026-06